Dr. Yasuhiro Shudo Promoted to Clinical Associate Professor of Cardiothoracic Surgery

by Roxanna Van Norman
February 17, 2025

The Stanford Department of Cardiothoracic Surgery is thrilled to announce the promotion of Yasuhiro Shudo, MD, PhD, to Clinical Associate Professor, effective February 16, 2025.

Dr. Shudo practices at Stanford Hospital, Stanford Health Care Tri-Valley, and Stanford-affiliated Santa Clara Valley Medical Center and O’Connor Hospital. His clinical focus is the surgical treatment of end-stage cardiopulmonary failure, including heart transplant, heart-lung transplant, lung transplant, mechanical circulatory support, and extracorporeal membrane oxygenation. Dr. Shudo is deeply committed to providing innovative, comprehensive, and compassionate care for every patient he treats.

"I am excited by this promotion and look forward to continuing the innovative work being done at Stanford. It’s a privilege to be part of a team that strives for excellence in patient care and research," said Dr. Shudo, who also serves as the Surgical Director of Extracorporeal Membrane Oxygenation. In addition to his expertise in transplantation, he performs mitral valve repair/replacement, aortic valve replacement, complex valve surgery, coronary artery bypass graft surgery, reoperative cardiac surgery, minimally invasive surgery, and transcatheter aortic valve replacement.

Dr. Shudo has extensive experience using organ preservation devices. In 2024, he and his procurement team used new industry technology for the first time at Stanford – and likely the first time in the United States – for a multiorgan transplant in a life-saving lung transplant operation. The team used the newly released second-generation lung protection device to preserve the donor's bilateral lung during its journey to Stanford. Soon after, they performed the first-in-the-world heart-lung transplant using this device.

Dr. Shudo received his medical degree from Osaka University Medical School in Japan in 2001. He completed his residency at Osaka University Hospital and Osaka Prefectural Hospital, followed by fellowships at Osaka Rosai Hospital and the same healthcare system. In 2013, he earned his PhD from Osaka University Graduate School of Medicine. Dr. Shudo then moved to the United States to complete a postdoctoral research fellowship at the University of Pennsylvania School of Medicine from 2011 to 2013, followed by another fellowship at Stanford School of Medicine from 2014 to 2015.

He became a clinical instructor in cardiothoracic transplant and mechanical circulatory support at Stanford from 2015 to 2017, and soon after joined the department as a clinical assistant professor in 2017. He currently directs the Stanford Translational Heart Failure Research Laboratory, where his research focuses on patients with end-stage heart failure. His laboratory has been developing innovative tissue engineering strategies that integrate bioengineering, biomechanics, and biostatistics to mitigate reperfusion injury.

Dr. Shudo is a member of the Society of Thoracic Surgeons and the International Society of Heart & Lung Transplantation and was recently nominated to the American Association for Thoracic Surgery. He is also a fellow of the American College of Cardiology and American Heart Association.

Please join us in congratulating Dr. Shudo on his promotion.